News briefs

Published: 1-Aug-2005
Ingredients

Arkema is to invest e4m to improve its chlorine handling and develop methane sulfonic acid (MSA) production at its Mourenx facility in France. The company, which supplies sulfonyls for a wide range of applications including pharmaceuticals, will also increase its MSA capacity by 50%.


Arkema is to invest e4m to improve its chlorine handling and develop methane sulfonic acid (MSA) production at its Mourenx facility in France. The company, which supplies sulfonyls for a wide range of applications including pharmaceuticals, will also increase its MSA capacity by 50%.

Johnson Matthey has developed the Smopex fibre family, based on its unique grafting technology, for use as metal scavengers. In the drug industry the product can be used to scavenge metals such as platinum, used in catalytic reactions for the production of APIs. The company has filed the first Smopex with the FDA: Smopex -111, a thiol functionalised fibre, which can now be used within a product stream containing an API.

SAFC, a member of the Sigma-Aldrich group, has completed a successful voluntary inspection by the MHRA of its facility in Manchester, UK. The site offers r&d labs, GMP suites and analytical support. The company also announced that it has signed an agreement with Cyntellect for Sigma-Aldrich to market CellXpress services for isolating high-titre cells for production of biotherapeutics.

exchem organics has completed a £3m investment in the latest process technologies for a new chemical plant at its 450 hectare site at Great Oakley near Harwich. The company provides manufacturing resources for multi-synthesis complex organic molecules to customers in the fine chemical and pharmaceutical industries.

Inveresk, the laboratory research, product development and clinical services company, was highlighting EU directive 2004/27/EC that outlines the requirement for a marketing authorisation application to be accompanied by an environmental risk assessment. The company said the final version is expected to be adopted later in 2005.

Halocarbon has launched hexa-fluoroisopropanol (HFIP)-norbornene monomers, as well as trifluoro-acetaldehyde hemiacetals, which have pharmaceutical applications. The key raw material in the manufacture of HFIP-NB monomers is hexa-fluoroacetone (HFA). Peter Murin, Halocarbon's ceo, commented: 'Years of experience in relieving our customers of the concerns of having to work with compounds like HFA made this area a natural fit.'

See more

You may also like

Ingredients

FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars

Read more
The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs

Trending Articles

  1. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
  2. Rousselot Rousselot is a global leader of gelatin and collagen-based solutions, serving the food, health & nutrition, biomedical, and pharmaceutical sectors. With our advanced Science & Innovation team, we unlock the secrets of the collagen molecule to create products that meet the highest standards of safety and quality. Through our state-of-the-art operations and extensive technical and formulation expertise, we help our customers achieve their goals, create world-class products, and we “Reach further together”. Rousselot is Darling’s Ingredients Health Brand.
  3. Debunking the myths of HPMC adoption Adopting new products, formulations and ways of working can be a challenge for industries as regulated as pharmaceuticals, writes Dr Subhashis Chakraborty, General Manager, Head of Global Product Management, at ACG Capsules
  4. Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
  5. Evonik increases plant-derived cholesterol supply The ingredient is used in the manufacture of mRNA vaccines and gene therapies

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Ingredients

FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars

The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
Ingredients

Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt

Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
Ingredients

Debunking the myths of HPMC adoption

Adopting new products, formulations and ways of working can be a challenge for industries as regulated as pharmaceuticals, writes Dr Subhashis Chakraborty, General Manager, Head of Global Product Management, at ACG Capsules
Ingredients

Meet Navetta: new approach to safety testing of drugs and particles

Turn inhalation research upside down
Ingredients

Shimadzu’s new UV-1900i Plus – smarter, faster UV-Vis spectrophotometer

Next-generation model offers ultra-fast scans and versatile measurement modes
Ingredients

IMCD bolsters API portfolio with Trichem Healthcare acquisition

This acquisition will bolster IMCD's portfolio of specialty pharmaceutical ingredients
Ingredients

BASF opens US GMP Solution Centre in Michigan

Catered towards its biopharma and small molecule customers, the site will provide excipients and bioprocessing ingredients to the US market
Subscribe now